Trans Genic Inc.

36
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3635720000
JPY
260.00
-35 (-11.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
13,083.00
11,429.00
12,576.00
11,046.00
11,046.00
8,674.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
13,083.00
11,429.00
12,576.00
11,046.00
11,046.00
8,674.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
47.00
28.00
22.00
28.00
32.00
6.00
General and Administration Expenses
2,084.00
1,982.00
1,958.00
1,854.00
1,678.00
1,176.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
12,980.00
11,454.00
10,739.00
10,150.00
10,983.00
8,404.00
Operating Profit (PBDIT) excl Other Income
103.00
-25.00
1,837.00
895.00
62.00
270.00
Other Income
35.00
22.00
1,475.00
23.00
-38.00
-6.00
Operating Profit (PBDIT)
289.00
180.00
3,540.00
1,170.00
254.00
453.00
Interest
47.00
28.00
22.00
28.00
32.00
6.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
150.00
183.00
227.00
251.00
229.00
190.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
43.00
-331.00
2,767.00
695.00
-249.00
202.00
Provision for Tax
39.00
108.00
907.00
152.00
191.00
0.00
Profit After Tax
4.00
-409.00
1,876.00
546.00
-440.00
202.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.24
-24.32
109.31
31.45
-25.38
11.91
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 14.47% vs -9.12% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 510.43% vs -101.37% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 66.79% vs 25.75% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 101.00% vs -121.83% in Mar 2023

Compare Profit and Loss Results of Trans Genic Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
13,083.00
5,082.00
8,001.00
157.44%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
13,083.00
5,082.00
8,001.00
157.44%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
47.00
42.00
5.00
11.90%
General and Administration Expenses
2,084.00
843.00
1,241.00
147.21%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
12,980.00
5,054.00
7,926.00
156.83%
Operating Profit (PBDIT) excl Other Income
103.00
27.00
76.00
281.48%
Other Income
35.00
86.00
-51.00
-59.30%
Operating Profit (PBDIT)
289.00
114.00
175.00
153.51%
Interest
47.00
42.00
5.00
11.90%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
150.00
0.00
150.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
43.00
72.00
-29.00
-40.28%
Provision for Tax
39.00
94.00
-55.00
-58.51%
Profit After Tax
4.00
-21.00
25.00
119.05%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.2431
-0.5219
0.77
146.58%
Profit And Loss - Net Sales
Net Sales 13,083.46 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 14.47% vs -9.12% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 103.22 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 510.43% vs -101.37% in Mar 2023

Profit And Loss - Interest
Interest 47.48 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 66.79% vs 25.75% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 4.08 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 101.00% vs -121.83% in Mar 2023